Fundz

Spero Therapeutics Announces CEO Transition and Consulting Plans

PUBLIC · SPROOct 27, 2026

Position

Chief Operating Officer

Company

Spero Therapeutics

Timothy Keutzer
CambridgeBiotechnology

Description

Spero Therapeutics, Inc. has announced the retirement of Timothy Keutzer, its Chief Operating Officer, effective December 31, 2026. Mr

Who to call at Spero Therapeutics, and when

A new leader at Spero Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Spero Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Spero Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Spero Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Spero Therapeutics

Location

675 MASSACHUSETTS AVENUE

Cambridge, Maryland, United States

About

Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and MDR bacterial infections with high unmet need.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Spero Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Esther
Likely contact at this company
••••••••@••••••••

See Esther's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Spero Therapeutics's next move

Learn about Strategic plan

Spero Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.